IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1952 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Adverse drug reaction profile of nanoparticle versus conventional formulation of paclitaxel: An observational study

Brahmachari Ballari, Hazra Avijit, Majumdar Anup

Year : 2011| Volume: 43| Issue : 2 | Page no: 126-130

   This article has been cited by
1 Nanotechnology: A revolutionary approach to prevent breast cancer recurrence
Alaa T. Alshareeda, M.Z. Nur Khatijah, Batla S. Al-Sowayan
Asian Journal of Surgery. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Polyphenol-Based Paclitaxel Prodrug Self-Assembled Nanoplatform for Tumor Synergistic Therapy
Guoqiang Rong, Maomao Xu, Suxin Shi, Quanjun Yao, Wei Cheng, Dekang Sang, Weixiong Yu, Yumei Qian, Lingling Shan
Journal of Biomedical Nanotechnology. 2021; 17(11): 2198
[Pubmed]  [Google Scholar] [DOI]
3 Curcumin Nanoparticles Attenuate Lipotoxic Injury in Cardiomyocytes Through Autophagy and Endoplasmic Reticulum Stress Signaling Pathways
Yue Gu, Huan Xia, Xiao Chen, Jing Li
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
4 The past, present, and future of breast cancer models for nanomedicine development
Paz Boix-Montesinos, Paula M. Soriano-Teruel, Ana Armiñán, Mar Orzáez, María J. Vicent
Advanced Drug Delivery Reviews. 2021; 173: 306
[Pubmed]  [Google Scholar] [DOI]
5 Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, NanoxelTM
Alka Madaan,Pratibha Singh,Anshumali Awasthi,Ritu Verma,Anu T. Singh,Manu Jaggi,Shiva Kant Mishra,Sadanand Kulkarni,Hrishikesh Kulkarni
Clinical and Translational Oncology. 2013; 15(1): 26
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow